New Delhi [India], May 21 (ANI): Amid the ongoing pandemic, the government is considering the involvement of three or four more firms to ramp up the production of the drug 2DG, developed by the DRDO for the treatment of COVID-19 patients and do away with its scarcity.
New Delhi [India], May 21 (ANI): The Defence Research and Development Organisation (DRDO) has developed an antibody test kit for the early screening of COVID.
Tokyo [Japan], May 21 (ANI): The Japanese government on Friday gave the green signal for two more COVID-19 vaccines -- those developed by AstraZeneca and Moderna pharmaceutical giants -- to be added to the nation's vaccine portfolio, Kyodo news reported.
New Delhi [India], May 20 (ANI): The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in Kerala, an institute under the Department of Science and Technology has developed a multiplex RT-PCR kit, where the validation shows the kit has 97.3 per cent sensitivity and 1
Bengaluru (Karnataka) [India], May 20 (ANI): Over the past couple of years, Indian women's hockey team has established itself as strong contenders in Asia having won silver at the Asian Champions Trophy 2018, Asian Games in 2018, and Gold at the 2017 Asia Cup.
Washington [US], May 19 (ANI): COVID-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study.
Chandigarh (Haryana) [India], May 17 (ANI): Haryana will purchase anti-COVID drug 2DG developed by DRDO for treatment of coroanvirus patients, state Health Minister Anil Vij said.
New Delhi [India], May 17 (ANI): After the first batch of anti-COVID drug 2-DG developed by DRDO was released by Defence Minister Rajnath Singh here, it will be available only to AIIMS, Armed Forces Hospitals, DRDO hospitals and other places in need. While the drug shall be made available to
New Delhi [India], May 17 (ANI): After releasing the first batch of anti-COVID drug 2-DG developed by the Defence Research and Development Organisation (DRDO), Defence Minister Rajnath Singh on Monday termed the drug as a new ray of hope and said this is a great example of India's scienti
New Delhi [India], May 17 (ANI): Union Health Minister Dr Harsh Vardhan on Monday said that the recovery time from COVID-19 infection and oxygen dependency will be reduced by anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
New Delhi [India], May 17 (ANI): Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.